{
    "Trade/Device Name(s)": [
        "BD Vacutainer\u00ae Citrate Blood Collection Tubes",
        "BD Citrate Tube"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K240455",
    "Predicate Device Reference 510(k) Number(s)": [
        "K013971"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GIM"
    ],
    "Summary Letter Date": "October 31, 2024",
    "Summary Letter Received Date": "October 1, 2024",
    "Submission Date": "February 15, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood Specimen Collection Device"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time (PT)",
        "Activated Partial Thromboplastin Time (aPTT)",
        "International Normalized Ratio (INR)",
        "D-Dimer",
        "Anti-Factor Xa"
    ],
    "Specimen Type(s)": [
        "Venous blood",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "BD Vacutainer\u00ae Citrate Blood Collection Tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Vacuum blood collection",
        "Buffered sodium citrate anticoagulation"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device",
        "Tube",
        "Container",
        "Transport medium"
    ],
    "Document Summary": "FDA 510(k) summary for BD Vacutainer\u00ae Citrate Blood Collection Tubes used for venous blood specimen collection and plasma preparation for coagulation testing",
    "Indications for Use Summary": "Sterile, single-use tube for collection, containment, transport, and centrifugation of venous blood to obtain plasma for in vitro coagulation testing in clinical laboratory settings",
    "fda_folder": "Clinical Chemistry"
}